Voyageur Minerals Ltd. (VM.V)

0.0500 -0.0050 (-9.09%) At close: 02:19PM EDT

Voyageur Minerals Ltd.

4103B Center Street
Calgary, AB T2E 2Y6
Canada

https://voyageurpharmaceuticals.ca

Sector(s): Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Full-time employees: 

Key executives

Name	Title	Pay	Exercised	Year born
Mr. Brent Willis Bsc.Eng	President, CEO & Director	131k	N/A	1971
Mr. Bradley Craig Willis P.Eng.	Founder, COO & Director	125.5k	N/A	1971
Mr. Albert Deslauriers	Chief Financial Officer	32.4k	N/A	N/A

Amounts are as of 31 December 2022, and compensation values are for the last fiscal year ending on that date. Pay includes salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in CAD.

Description

Voyageur Pharmaceuticals Ltd., together with its subsidiaries, engages in the acquiring, exploring, and developing raw materials for pharmaceutical products in the province of British Columbia, Canada, and the state of Utah. It develops barium, iodine-based APIs, and imaging contrast agents for medical radiology. The company was formerly known as Voyageur Minerals Ltd. and changed its name to Voyageur Pharmaceuticals Ltd. in December 2019. Voyageur Pharmaceuticals Ltd. is headquartered in Calgary, Canada.

Corporate governance

Voyageur Minerals Ltd.’s ISS governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while 10 indicates higher governance risk.